Skip to content

Safety of Antibiotic Intake During Pregnancy

Safety of Antibiotic Intake During Pregnancy: Results of Questionnaire of Pregnant Women in Two Arab Countries

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05810935
Acronym
antibiotic
Enrollment
384
Registered
2023-04-13
Start date
2023-05-31
Completion date
2024-05-31
Last updated
2023-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infections

Keywords

antibiotics, infection

Brief summary

this study will be conducted to assess the knowledge of the pregnant females regarding safety of antibiotic intake ,also their attitude toward any prescribed antibiotics during their pregnancy .

Detailed description

this study will be conducted on pregnant females from two Arab countries to assess their knowledge and attitude toward any prescribed antibiotics while they are pregnant .Also to assess any malpractice while their intake for any antibiotics . this study is a cross sectional study that will involve a questionnaire including the three mentioned domains .

Interventions

None listed

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* pregnant women at any gestational age

Exclusion criteria

* pregnant women who refused to participate

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with antibiotic-related side effectsthrough study completion ,an average of one yearusing a questionnaire to measure the knowledge and attitude of pregnant women toward antibiotics that were taken during pregnancy and any malpractice during its intake

Contacts

Primary ContactEman Ibrahim Abd Elrehim, Lecturer
ahmedea2003@gmail.com02 01110985494

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026